We have located links that may give you full text access.
Human Serum Albumin-Delivered [Au(PEt 3 )] + Is a Potent Inhibitor of T Cell Proliferation.
ACS Medicinal Chemistry Letters 2017 May 12
Using a modular library format in conjunction with cell viability (MTS) and flow cytometry assays, 90 cationic complexes [Au PL ] n + ( P = phosphine ligand; L = thiourea derivative or chloride) were studied for their antiproliferative activity in CD8+ T lymphocyte cells. The activity of the compounds correlates with the steric bulk of the phosphine ligands. Thiourea serves as a leaving group that is readily replaced by cysteine thiol (NMR, ESI-MS). Taking advantage of selective thiourea ligand exchange, the fragments [Au(PEt3 )]+ and [Au(JohnPhos)]+ (JohnPhos = 1,1'-biphenyl-2-yl)di- tert -butylphosphine) in compounds 1 and 2 were transferred to recombinant human serum albumin (rHSA). PEt3 promoted efficient modification of Cys34 in HSA ( HSA-1 ), whereas use of bulky JohnPhos as a carrier ligand led to serum protein nonspecifically modified with multiple gold adducts ( HSA-2 ) (Ellman's test, ESI-TOF MS). HSA-1 , but not HSA-2 , strongly inhibits T cell proliferation at nanomolar doses. The potential role of HSA as a delivery vehicle in gold-based autoimmune disease treatment is discussed.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app